Emerging Company Profile

How D3 Bio is building its biomarker-driven pipeline

Emerging Company Profile: D3 Bio’s Chen on the start-up’s internal pipeline, plans for in-licensing

D3 Bio’s George Chen on the Shanghai start-up’s internal pipeline and plans for in-licensing.

George Chen’s D3 Bio is prioritizing  its internal pipeline so it can be choosy about